Cosmos Health
Tracked across 5 events · 33 articles · First seen Jun 01, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Cosmos Health>>> announced its entry into the global animal health market with the planned launch of a veterinary formulation of C-Scrub Wash 4%. This antimicrobial wash, already established for human use, successfully passed independent European…
Impact: Cosmos Health is expanding its product line into the animal health market with the launch of C-Scrub Wash 4% for veterinary use, which is expected to open new commercial opportunities and revenue streams for the company.
Jun 01, 2026 · 7 articles
Business
Cosmos Health announced its intention to monetize approximately $20 million in non-core assets, including real estate such as the CosmoFarm distribution facility and Abbott Laboratories manufacturing site, as well as digital assets and marketable securities.…
Impact: Cosmos Health is exploring the monetization of approximately $20 million in non-core assets to strengthen its balance sheet, fund strategic initiatives, and potentially eliminate debt, which could significantly improve its financial position and market valuation.
Jun 04, 2026 · 6 articles
Business
Cosmos Health>>> announced that its proprietary brand, Sky Premium Life>>>, has achieved pan-European distribution across all 27 European Union>>> Member States through the e-commerce platform Skroutz>>>. This expansion makes 96 Sky Premium Life>>> products accessible…
Impact: Cosmos Health has significantly expanded the distribution of its proprietary brand, Sky Premium Life, across all 27 European Union Member States through Skroutz, which is a key milestone in its international growth strategy, enhancing brand visibility and supporting revenue growth.
Jun 04, 2026 · 6 articles
Business
Cosmos Health Inc., through its wholly owned subsidiary Abbott Laboratories S.A., has acquired the international patent application WO2025108566A1 from Cloudpharm P.C. This acquisition is a strategic move to strengthen Cosmos Health's proprietary intellectual property portfolio…
Impact: Cosmos Health Inc. has strengthened its proprietary IP portfolio and expanded its nanotechnology investment initiatives through the acquisition of a patent application, which is expected to drive long-term shareholder value and support the development of next-generation healthcare products.
Jun 08, 2026 · 8 articles
Business
Cosmos Health Inc. has been granted an additional 180-day period by Nasdaq-100, extending until December 7, 2026, to regain compliance with the minimum $1.00 bid price requirement. The company is compliant with all other Nasdaq-100…
Impact: Cosmos Health received an additional 180-day extension from Nasdaq-100 to regain compliance with the minimum bid price requirement, which is positive for its continued listing but highlights ongoing stock price challenges.
Jun 11, 2026 · 6 articles
100
Cosmos Health expanded distribution European UnionCosmos Health expands Sky...
100
Nasdaq-100 granted extension Cosmos HealthCosmos Health gets Nasdaq extension
90
Cosmos Health announced brand extensionCosmos Health launches...
90
Cosmos Health identified assets for monetizationCosmos Health Monetizes...
90
Cosmos Health received notification Nasdaq-100Cosmos Health gets Nasdaq extension
80
Cosmos Health intends to launch United KingdomCosmos Health launches...
70
Cosmos Health committed to core operationsCosmos Health Monetizes...
70
Cosmos Health does not intendCosmos Health gets Nasdaq extension
Greg Siokas
ceo
↔
Cosmos Health
Greg Siokas has served as the CEO of Cosmos Health since February 2016 and holds
NEWSDESK
Track Cosmos Health live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard